Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01873040 · ClinicalTrials.gov registry record · NA
Vaccine Social Media Randomized Intervention Trial
A NA study, sponsored by Kaiser Permanente.
- Completed
- Registry status
- NA
- Development phase
- 1,675
- Enrollment target
NCT01873040: Completed NA study, sponsored by Kaiser Permanente.
NCT01873040 is a NA study that has completed, run by Kaiser Permanente. The registered enrollment target is 1,675 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (19% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01873040, a NA study, has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,675 participants
- Enrollment target
Study Summary
This study will assess the effectiveness of social media website devoted to vaccines to change immunization knowledge, perceptions and behavior. If effective, this intervention will represent an innovative, low cost and broadly applicable resource to reduce parental vaccination concerns. The study has two hypothesis: 1. Parents receiving usual care plus social media website will demonstrate higher early childhood immunization rates to parents receiving either usual plus non interactive website or usual care only. 2. Parents receiving usual care plus social media website will demonstrate positive changes in knowledge, attitudes and beliefs supporting vaccination compared to parents receiving either usual care plus non-interactive website or usual care only.
Primary Outcome
Days under-immunized is a metric to identify immunization delay. For each vaccine dose calculate the difference between when the vaccine dose was actually administered and when the vaccine dose should have been administered according to the Advisory Committee on Immunization Practices (ACIP) schedule. That difference is summed across all doses and vaccines for a total number of days under-immunized for each child. Total days under immunized was calculated 200 days after life or after enrollment.
Interventions
- BEHAVIORAL Social Media plus information pages
- BEHAVIORAL Vaccine Information Pages
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,675 participants |
| Start Date | 2013-08 |
| Est. Completion | 2016-11 |
| Phase | NA |
What the finished NCT01873040 record still lists
NCT01873040 is an interventional study that assigns participants to a tested intervention. Its 1,675 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (19% higher).
The record links to 0 conditions, and to 2 interventions - of which Social Media plus information pages is the first listed.
NCT01873040 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01873040 about?
NCT01873040 is a clinical study titled "Vaccine Social Media Randomized Intervention Trial". This study will assess the effectiveness of social media website devoted to vaccines to change immunization knowledge, perceptions and behavior. If effective, this intervention will represent an innovative, low cost and broadly applicable resource to reduce parental vaccination concerns. The study ...
What is the current status of trial NCT01873040?
This trial is currently completed. It is a NA study. The enrollment target is 1,675 participants. The study started on 2013-08. Estimated completion is 2016-11.
What interventions are being tested in trial NCT01873040?
The interventions under investigation include: Social Media plus information pages (BEHAVIORAL), Vaccine Information Pages (BEHAVIORAL).
Who is sponsoring clinical trial NCT01873040?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01873040's enrollment target sits among peer trials
1,675 62nd of 2000 higher than 1,939 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06376565 · 1,680 participants · NA
Improving Colonoscopy Surveillance for Patients With High Risk Colon Polyps
- NCT04852887 · 1,670 participants · Phase 3
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
- NCT06644625 · 1,665 participants
CHAAMP (CHArlotte Advocate MGUS Project) Internal Pilot Study
- NCT06034405 · 1,663 participants
Analysis of Lumbar Spine Stenosis Specimens for Identification of Transthyretin Cardiac Amyloidosis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia